The novel treatment of the medication represents a major advance in the management of the condition. Unlike existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and glucose-dependent https://tirzepatide-peptide840803.acidblog.net/73308826/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment